Viking Therapeutics (VKTX) Tops Q4 EPS by 3c
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.